When it comes to the successful preclinical testing of medical devices, experience matters. NAMSA has the largest depth of therapeutic expertise of any development partner on the planet — backed by over 50 years in business. That equates to unparalleled preclinical laboratory support for sponsors in the United States, United Kingdom, Ireland, Spain, France, Germany and many other countries worldwide.
NAMSA’s preclinical research services support all model types, treatments and implant requirements, including:
- Cardiovascular
- Dental
- Dermal
- Electrophysiology
- Gastrointestinal
- Neuromodulation
- Orthopedics
- Pulmonary
- Urogenital
- Wound Healing
- and many others
Our highly sought-after global teams are experts at helping utilize data to bridge preclinical safety endpoints to proposed clinical endpoints, allowing clinical labs to standardize measurements and obtain expert interpretations of results. We can also support early feasibility testing with non-GLP surgical studies intended to provide iteration and proof-of-concept prior to an investment in GLP programs.
NAMSA keeps cutting-edge imaging technology at the heart of all preclinical research services, including:
- Diagnostic imaging for visualizing implants
- Diagnosing defects or disease
- Documenting research outcomes
In addition, NAMSA’s surgical staff — including Doctors of Veterinary Medicine and Academy of Surgical Research-certified — are equipped with the necessary tools to support your entire procedure or to fill procedural role gaps as needed. When you need thorough laboratory research or preclinical testing of medical devices, NAMSA’s team is here to provide the expertise.